First Clinical Application of an Actively Reversible Direct Factor IXa Inhibitor as an Anticoagulation Strategy in Patients Undergoing Percutaneous Coronary InterventionMauricio G. Cohen, Richard C. Becker, Drew A. Purdy et al.|Circulation|2010Cited by 98
2020 American Heart Association and American College of Cardiology Consensus Conference on Professionalism and Ethics: A Consensus Conference ReportIvor J. Benjamin, Richard E. Anderson, Robert A. Harrington et al.|Circulation|2021Cited by 30
2020 American Heart Association and American College of Cardiology Consensus Conference on Professionalism and Ethics: A Consensus Conference ReportIvor J. Benjamin, Richard E. Anderson, C. Michael Valentine et al.|Journal of the American College of Cardiology|2021Cited by 21